Levomepromazine
Back to searchMolecule Structure
Scientific Name
Levomepromazine
Description of the Drug
Methotrimeprazine is a phenothiazine used in the management of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01403
http://www.drugbank.ca/drugs/DB01403
Brand Name(s)
Levomepromazine, Levoprome, Nirvan, Tisercin
Company Owner(s)
Immunex Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL25462 | |
| PharmGKB | PA164743234 | |
| Human Metabolome Database | HMDB0015474 | |
| DrugBank | DB01403 | |
| PubChem: Thomson Pharma | 16500237 | |
| PubChem | 72287 | |
| LINCS | LSM-2778 | |
| Nikkaji | J76.892H | |
| BindingDB | 50418049 | |
| EPA CompTox Dashboard | DTXSID1023289 | |
| DrugCentral | 1752 | |
| Brenda | 167771 | |
| ChemicalBook | CB5488571 | |
| Guide to Pharmacology | 7603 | |
| rxnorm | METHOTRIMEPRAZINE | LEVOMEPROMAZINE MALEATE |
| KEGG Ligand | C07192 | |
| ChEBI | 6838 | |
| ZINC | ZINC000000020246 |
